HealthInvest Partners AB Invests $10.39 Million in Anthem, Inc. (ANTM)

HealthInvest Partners AB bought a new stake in Anthem, Inc. (NYSE:ANTM) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 55,200 shares of the company’s stock, valued at approximately $10,385,000. Anthem accounts for about 12.9% of HealthInvest Partners AB’s portfolio, making the stock its largest position.

Other institutional investors have also added to or reduced their stakes in the company. Guardian Life Insurance Co. of America boosted its position in Anthem by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 1,016 shares of the company’s stock valued at $168,000 after buying an additional 7 shares during the last quarter. Sii Investments Inc. WI raised its stake in shares of Anthem by 0.4% in the first quarter. Sii Investments Inc. WI now owns 2,713 shares of the company’s stock valued at $444,000 after buying an additional 12 shares during the period. Cedar Wealth Management LLC raised its stake in shares of Anthem by 1.7% in the second quarter. Cedar Wealth Management LLC now owns 908 shares of the company’s stock valued at $171,000 after buying an additional 15 shares during the period. Dowling & Yahnke LLC raised its stake in shares of Anthem by 0.3% in the second quarter. Dowling & Yahnke LLC now owns 7,175 shares of the company’s stock valued at $1,350,000 after buying an additional 18 shares during the period. Finally, Financial Architects Inc raised its stake in shares of Anthem by 1.9% in the second quarter. Financial Architects Inc now owns 1,310 shares of the company’s stock valued at $246,000 after buying an additional 25 shares during the period. Institutional investors own 89.48% of the company’s stock.

Anthem, Inc. (NYSE:ANTM) traded up 0.63% during midday trading on Tuesday, reaching $194.18. The company had a trading volume of 230,221 shares. The company’s 50 day moving average is $190.53 and its 200-day moving average is $178.01. Anthem, Inc. has a 52-week low of $114.85 and a 52-week high of $194.94. The company has a market capitalization of $50.99 billion, a P/E ratio of 18.36 and a beta of 0.73.

Anthem (NYSE:ANTM) last posted its quarterly earnings data on Wednesday, July 26th. The company reported $3.37 EPS for the quarter, topping analysts’ consensus estimates of $3.23 by $0.14. Anthem had a net margin of 3.24% and a return on equity of 12.93%. The firm had revenue of $22.20 billion during the quarter, compared to analyst estimates of $22.25 billion. During the same quarter last year, the business posted $3.33 EPS. The company’s revenue was up 4.3% on a year-over-year basis. Equities analysts expect that Anthem, Inc. will post $11.82 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Monday, September 25th. Investors of record on Friday, September 8th will be paid a $0.70 dividend. This is a positive change from Anthem’s previous quarterly dividend of $0.65. The ex-dividend date is Thursday, September 7th. This represents a $2.80 dividend on an annualized basis and a yield of 1.45%. Anthem’s dividend payout ratio (DPR) is currently 24.62%.

ILLEGAL ACTIVITY NOTICE: “[[title]]” was published by [[site]] and is the sole property of of [[site]]. If you are accessing this piece on another publication, it was stolen and republished in violation of international copyright and trademark legislation. The correct version of this piece can be accessed at [[permalink]].

Several brokerages have recently commented on ANTM. Jefferies Group LLC reissued a “hold” rating and set a $204.00 price target on shares of Anthem in a research note on Sunday. Morgan Stanley boosted their price target on Anthem from $196.00 to $201.00 and gave the stock an “equal weight” rating in a research note on Thursday, August 17th. Cantor Fitzgerald reissued an “overweight” rating and set a $215.00 price target (up previously from $210.00) on shares of Anthem in a research note on Wednesday, July 26th. BidaskClub lowered Anthem from a “buy” rating to a “hold” rating in a research note on Monday, July 31st. Finally, Deutsche Bank AG boosted their price target on Anthem from $173.00 to $185.00 and gave the stock a “hold” rating in a research note on Thursday, July 13th. Eleven investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. The company has a consensus rating of “Hold” and a consensus price target of $181.76.

In related news, SVP Ronald W. Penczek sold 867 shares of the firm’s stock in a transaction that occurred on Wednesday, June 7th. The shares were sold at an average price of $187.46, for a total value of $162,527.82. Following the completion of the transaction, the senior vice president now owns 1,872 shares of the company’s stock, valued at approximately $350,925.12. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Thomas C. Zielinski sold 9,127 shares of the firm’s stock in a transaction that occurred on Thursday, August 10th. The stock was sold at an average price of $191.25, for a total transaction of $1,745,538.75. Following the completion of the transaction, the executive vice president now directly owns 26,571 shares of the company’s stock, valued at approximately $5,081,703.75. The disclosure for this sale can be found here. Insiders sold a total of 13,754 shares of company stock valued at $2,595,073 in the last ninety days. Company insiders own 0.36% of the company’s stock.

About Anthem

Anthem, Inc is a health benefits company. The Company operates through three segments: Commercial and Specialty Business, Government Business and Other. It offers a spectrum of network-based managed care plans to large and small employer, individual, Medicaid and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; indemnity plans and other hybrid plans, including consumer-driven health plans; and hospital only and limited benefit products.

Want to see what other hedge funds are holding ANTM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Anthem, Inc. (NYSE:ANTM).